- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Patent holdings for IPC class A61K 31/519
Total number of patents in this class: 19269
10-year publication summary
|
1316
|
1394
|
1384
|
1574
|
1616
|
1703
|
1758
|
1632
|
1600
|
819
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10904 |
296 |
| Incyte Corporation | 1011 |
277 |
| Boehringer Ingelheim International GmbH | 4704 |
233 |
| Janssen Pharmaceutica N.V. | 3423 |
173 |
| F. Hoffmann-La Roche AG | 7926 |
169 |
| Pfizer Inc. | 3367 |
166 |
| Merck Sharp & Dohme LLC | 3741 |
164 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
161 |
| Pharmacyclics LLC | 238 |
158 |
| AstraZeneca AB | 2928 |
157 |
| The Regents of the University of California | 19812 |
152 |
| Genentech, Inc. | 3961 |
147 |
| Gilead Sciences, Inc. | 2028 |
147 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
142 |
| Bristol-myers Squibb Company | 4892 |
129 |
| Takeda Pharmaceutical Company Limited | 2704 |
129 |
| Hoffmann-La Roche Inc. | 3379 |
127 |
| Merck Patent GmbH | 5850 |
127 |
| Incyte Holdings Corporation | 653 |
124 |
| Amgen Inc. | 4047 |
123 |
| Other owners | 15968 |